Differential Diagnosis Between Graft-Versus-Host Disease and Hemophagocytic Syndrome After Living-Related Liver Transplantation by Mixed Lymphocyte Reaction Assay-Reference-Cited by-同舟云学术

Differential Diagnosis Between Graft-Versus-Host Disease and Hemophagocytic Syndrome After Living-Related Liver Transplantation by Mixed Lymphocyte Reaction Assay

Published:2004-01 Issue:4 Volume:17 Page:197-202
ISSN:0894-1939
Container-title:Journal of Investigative Surgery
language:en
Short-container-title:Journal of Investigative Surgery

Author:

Hara Hidetaka,Ohdan Hideki,Tashiro Hirotaka,Itamoto Toshiyuki,Tanaka Yuka,Mizunuma Kazuyuki,Tokita Daisuke,Onoe Takashi,Ito Reiko,Asahara Toshimasa

Publisher

Informa UK Limited

Subject

Surgery

Link

http://www.tandfonline.com/doi/pdf/10.1080/08941930490471966

Reference14 articles.

1. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing

2. Syndrome d’activation macrophagique

3. FATAL HEMOPHAGOCYTIC SYNDROME AFTER LIVING-RELATED LIVER TRANSPLANTATION

4. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.

5. TRANSFUSION-INDUCED GRAFT-VERSUS-HOST DISEASE AFTER LIVER TRANSPLANTATION

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemophagocytic lymphohistiocytosis after solid organ transplantation: A challenge for clinicians;Transplant Immunology;2024-04

2. Graft-versus-host disease following liver transplantation: A systematic review of literature;Hepatology Communications;2023-09-27

3. Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review;Journal of Clinical Medicine;2022-10-26

4. Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD;International Journal of Hematology;2021-03-08

5. Improved survival after LTx-associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single-center experience and systematic review;American Journal of Transplantation;2018-06-23